Actavis – Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg

← Back to Drug Recalls

Recall Category: Drug Recalls

Date: 06/05/2020

Brand: Actavis

Product: Metformin Hydrochloride Extended-Release Tablets, USP 500mg and 750mg

Recall Reason: Due to detection of N-Nitrosodimethylamine (NDMA)

Company: Teva Pharmaceuticals USA Inc.

Dosage Form: Tablet

Recall Issue Type: Other Recall Issue

View FDA Drug Recall Notice